Cook Medical has announced it has received FDA approval for the first devices in its zilver ptx drug-eluting peripheral stent portfolio, according to a news release.
The Zilver PTX drug-eluting stent is intended to treat peripheral arterial disease in the superficial femoral artery. Cook Medical reported that it is the first time FDA has approved a drug-eluting stent to treat blockages in a peripheral artery.
"This approval marks the start of Cook's program to bring the benefits of drug elution to U.S. physicians treating the peripheral arteries," said Rob Lyles, vice president and global leader of Cook Medical's peripheral intervention division, in the release. "No other company can match Cook's commitment to this technology, and by the end of 2013, we expect to have a full suite of drug-eluting peripheral stents in the most commonly used lengths and diameters available to U.S. physicians."
Cook Medical has its North and South American headquarters in Bloomington, Ind.
Related Articles on FDA Clearances:
Quantel Medical Receives FDA Clearance for Ophthalmic Laser System
Vitacon Receives FDA Clearance for Bladder Scanner
Vital Images Receives FDA Clearance for 3-D Viewing Through VitreaView